期刊文献+

服用米非司酮对子宫肌瘤患者糖皮质激素的影响及缩瘤效果的观察 被引量:9

原文传递
导出
摘要 目的:观察长疗程服用米非司酮治疗子宫肌瘤的效果及对糖皮质激素的影响。方法:60例子宫肌瘤患者,从月经12天开始,每日口服米非司酮5 mg,连续服6个月。分别于治疗前、治疗3个月和治疗6个月测量子宫及肌瘤的三维径线,用免疫化学发光法测定血清皮质醇(C)、雌二醇(E2)、孕酮(P)、促黄体生成素(LH)、促卵泡素(FSH),并检查肝肾功能和血红蛋白,记录患者的不良反应。结果:用药6个月肌瘤体积缩小了59.2%,与服药3个月相比,差异有统计学意义(P〈0.01)。治疗3个月,35%的(14/40)患者出现抗糖皮质激素症状,治疗6个月症状无明显加重。有抗糖皮质激素症状患者血清皮质醇治疗3个月时明显升高(23%),而治疗6个月时明显降低(26.8%),P〈0.05,与无抗糖皮质激素症状患者相比较,差异有统计学意义,P〈0.05。结论:口服米非司酮5mg 6个月,部分患者出现轻度抗糖皮质激素效应伴随血清皮质醇的波动;测定血清皮质醇水平可能不适合用来判断有无米非司酮抗糖皮质激素效应发生;长疗程用药后子宫肌瘤明显缩小。
出处 《中国妇幼保健》 CAS 北大核心 2011年第6期842-843,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献6

  • 1Murphy AA, Moral AJ, Kettle LM et al. Regression of uterine leiomyomata to the antiprogesterone RU486: dose response effect [J] . Fertil Steril, 1995, 64 (1): 187.
  • 2Murphy AA, Kettle LM, Moral AJ et al. Regression of uterine leiomyomata in response to the antiprogesterone RU486 [ J] . Clin Endocrinol Meteb, 1993, 76 (2): 513.
  • 3Heikinheimo O. Raivio T, Honkanen H et al. Termination of pregnancy with tnifepristone and prostaglandin suppresses transiently circulating glucocorlicoid bioactivity [ J ] . Clin Endocrinol Metab, 2003, 88 (1): 323.
  • 4Bertagna X, Bertagna C, Luton JP et al. The new steroid analogue RU486 inhibits glucocnrticoid action in man [ J] . Clin Endocrinol Metab, 1984, 59 (1): 25.
  • 5Steven H, Eisinger MD, Sean Meldrum MS et al. Low dose mifepristone for uterine leiomyomata [J] . Obstet Gynecol, 2003, 101 (2) : 243.
  • 6霍艳,王惠兰,韩敏.长疗程服用米非司酮对子宫肌瘤患者糖皮质激素的影响及缩瘤效果的观察[J].实用妇产科杂志,2007,23(10):630-632. 被引量:11

二级参考文献8

  • 1Murphy AA, Moral AJ, Kettle LM, et al. Regression d uterine leiomy-omata to the antiprogesterone RU486: dose-response effect[J]. Fertil Steril, 1995, 64(1): 187.
  • 2Murphy AA, Kettle LM, Moral AJ, et al. Regression of uterine leiomy-omata in response to the anfiprogesterone RU486 [ J ] . CAin Endocrinol Meteb, 1993, 76(2): 513.
  • 3Heikinheimo O, Raivio T, Honkanen H, et al. Termination d pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocortieoid bioactivity[J]. Clin Endocrinol Metab, 2003, 88(1): 323- 326.
  • 4Bertagna X,Bertagna C,Luton JP, et 81. The new steroid analogue RU486 inhibits glucocorticoid action in man[J]. Clin Endocrinol Metab,1984,59(1):25.
  • 5Steven H, Eisinger MD, Sean Meldrum MS, et 81. Low-Dose mifepristone for uterine leiomyomata [J]. Obstet Gynecol, 2003, 101(2):243-250.
  • 6Sliverstre L, Dubois C, Renault M. Voluntary interruption of pregnancy with mifepristone and a prostaglandin analogue[J]. N Engl J Med, 1990, 322(10): 645-648.
  • 7Gravanis A, Schiason G, George M, el al. Endometrlal and pituitary responses to the steroidal antiprogestin RU486 in postmenopausal women[J]. Clin Endocrinol Metab, 1985, 60(1): 156-163.
  • 8Spitz IM, Croxatto HB, Robbin A. Antiprogestin mechanism of action and contraceptive potential[J]. Ann Rev Pharamacol Toxieol, 1996, 36: 47- 81.

共引文献10

同被引文献54

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部